Vanguard Capital Management
BOLD icon

Vanguard Capital Management’s Boundless Bio BOLD Stock Holding History

Vanguard Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.5M Sell
597,192
-17,731
-3% -$47.8K ﹤0.01% 3454
2026
Q2 		$1.54M Buy
614,923
+17,731
+3% +$27.3K ﹤0.01% 3497
2026
Q1 		$657K Buy
+597,192
New +$698K ﹤0.01% 3631

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
RBF Capital
RBF Capital San Francisco, California $2.3B AUM 22.6% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management's BOLD Position: Q3 2026 in Review

Vanguard Capital Management reduced its Boundless Bio (BOLD) stake by 2.9% in Q3 2026, selling an estimated $47.8K and leaving 597,192 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Vanguard Capital Management first reported a position in BOLD in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.54M in Q2 2026. 25 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • Vanguard Capital Management held 597,192 shares of Boundless Bio worth $1.5M as of Q3 2026.
  • Vanguard Capital Management sold 17,731 Boundless Bio shares in Q3 2026, an estimated $47.8K.
  • Boundless Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3454 holding.
  • Vanguard Capital Management first reported a position in Boundless Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Boundless Bio position peaked at $1.54M in Q2 2026.
  • 25 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.